Sickle Cell Disease and Gallstones: Risks, Management & Surgery

Why are gallstones so common in sickle cell disease?

Sickle cell disease (SCD) is an inherited hemoglobinopathy causing chronic hemolytic anemia. The lifelong breakdown of red blood cells releases large amounts of unconjugated bilirubin. The liver conjugates bilirubin, but unconjugated bilirubin can precipitate in bile as calcium bilirubinate – forming black pigment gallstones.

Key factors:

• Chronic hemolysis: Increased bilirubin load overwhelms conjugation capacity, leading to elevated unconjugated bilirubin in bile.
• Bile stasis: SCD can cause gallbladder hypomotility, promoting stone formation.
• Recurrent transfusions: May increase iron load and bilirubin production.

Prevalence and natural history

Gallstones are extremely common in SCD:

• Children: 10‑20% by age 10 years.
• Adolescents: 30‑40% by age 15‑18.
• Adults: 50‑70% by age 30.
• Hemoglobin SC disease: Slightly lower risk than SS but still elevated.

Most stones are asymptomatic. However, symptomatic cholelithiasis (biliary colic, acute cholecystitis, choledocholithiasis) occurs in 10‑30% of patients over their lifetime. Complications include cholangitis, gallstone pancreatitis, and (rarely) gallbladder cancer.

Clinical presentation – mimicking vaso‑occlusive crisis

Right upper quadrant (RUQ) pain in SCD can be from gallstones OR from hepatic sequestration, acute chest syndrome, or rib infarction. Distinguishing features:

• Biliary colic: Postprandial (especially after fatty meals), episodic, may radiate to right shoulder or back.
• Acute cholecystitis: Constant pain, fever, tenderness, Murphy’s sign, leukocytosis.
• Vaso‑occlusive crisis: Diffuse bone pain, fever less common, no specific relationship to meals.
• Hepatic sequestration: Rapid liver enlargement, severe pain, drop in hemoglobin.

Up to 30% of SCD patients undergoing cholecystectomy have atypical presentations, so a high index of suspicion is needed.

Diagnosis: ultrasound and distinguishing from abdominal crisis

Abdominal ultrasound is the first‑line imaging modality:

• Detects gallstones (hyperechoic foci with acoustic shadowing). Pigment stones may be radiopaque on plain X‑ray but ultrasound is preferred.
• Assesses gallbladder wall thickness (>3 mm suggests cholecystitis), pericholecystic fluid, common bile duct diameter.
• Can detect biliary sludge (common in SCD even without stones).

If choledocholithiasis is suspected (elevated alkaline phosphatase, bilirubin, or dilated CBD), MRCP or EUS is indicated. ERCP is therapeutic but carries higher risk in SCD (see below).

When to operate: asymptomatic vs. symptomatic stones

Guidelines (e.g., American Society of Hematology, 2020) recommend:

• Asymptomatic gallstones: Observation is safe. Prophylactic cholecystectomy is NOT routinely recommended because most remain asymptomatic, and surgery carries higher risk in SCD (sickle cell crisis, acute chest syndrome, infection).
• Symptomatic gallstones (biliary colic, cholecystitis): Laparoscopic cholecystectomy is indicated. Surgery should be performed electively after optimization (see below).
• Recurrent biliary colic or complications: Operate even if symptoms are mild – they tend to progress.
• Choledocholithiasis: ERCP followed by cholecystectomy (same admission if possible).

In children, some centres offer prophylactic cholecystectomy at age 10‑15 if stones are present, but evidence is mixed. Shared decision‑making is key.

Perioperative management – transfusion guidelines and complications

Surgery in SCD patients carries increased risks: vaso‑occlusive crisis, acute chest syndrome, stroke, and infection. Preoperative optimization is critical.

Preoperative transfusion (controversial):

• Simple transfusion to raise hemoglobin to 8‑10 g/dL (if Hb <7).
• Exchange transfusion (reduce HbS to <30‑50%) is recommended for major surgery (including cholecystectomy) by some experts, though evidence is weak. The TAPS study (2019) showed no benefit of aggressive exchange over simple transfusion for low‑risk surgery.
• Current practice: Many centres use simple transfusion to target Hb 9‑10 g/dL and HbS <60%. Exchange is reserved for patients with severe SCD or previous complications.

Perioperative precautions:

• Maintain hydration, oxygenation, normothermia.
• Avoid hypoxia, acidosis, and hypotension (trigger sickling).
• Use incentive spirometry to prevent acute chest syndrome.
• Postoperative monitoring for pain crisis, fever, respiratory distress.

Complication rates: up to 20% have post‑op sickle cell crisis; acute chest syndrome in 5‑10%. Elective surgery in a specialized centre reduces risk.

Prevention: does UDCA (ursodiol) help?

Ursodeoxycholic acid (UDCA) reduces cholesterol saturation but has no effect on pigment stone formation (which is bilirubin‑driven). However, UDCA may reduce biliary sludge and possibly prevent stone progression in SCD. Studies:

• Small trials suggest UDCA (10‑15 mg/kg/day) reduces sludge and improves gallbladder emptying in SCD children.
• No large RCT has shown prevention of symptomatic gallstones or need for cholecystectomy.
• Current recommendation: Not routinely indicated. Consider in patients with biliary sludge or recurrent abdominal pain without stones.

Hydroxyurea (to reduce hemolysis) may theoretically lower gallstone risk by decreasing hemolysis, but no direct evidence.

Interactive FAQ – Sickle cell and gallstones

Disclaimer: This information is for educational purposes. Management of gallstones in sickle cell disease should be multidisciplinary (hematology + surgery). Consult a specialist at Vivekananda Hospital for personalised care.